These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10220336)

  • 1. The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site.
    Hamel E; Sackett DL; Vourloumis D; Nicolaou KC
    Biochemistry; 1999 Apr; 38(17):5490-8. PubMed ID: 10220336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)).
    Kowalski RJ; Giannakakou P; Hamel E
    J Biol Chem; 1997 Jan; 272(4):2534-41. PubMed ID: 8999970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).
    Long BH; Carboni JM; Wasserman AJ; Cornell LA; Casazza AM; Jensen PR; Lindel T; Fenical W; Fairchild CR
    Cancer Res; 1998 Mar; 58(6):1111-5. PubMed ID: 9515790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
    Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule structure at improved resolution.
    Meurer-Grob P; Kasparian J; Wade RH
    Biochemistry; 2001 Jul; 40(27):8000-8. PubMed ID: 11434769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines.
    McDaid HM; Bhattacharya SK; Chen XT; He L; Shen HJ; Gutteridge CE; Horwitz SB; Danishefsky SJ
    Cancer Chemother Pharmacol; 1999; 44(2):131-7. PubMed ID: 10412947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.
    Gapud EJ; Bai R; Ghosh AK; Hamel E
    Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly.
    Hamel E; Day BW; Miller JH; Jung MK; Northcote PT; Ghosh AK; Curran DP; Cushman M; Nicolaou KC; Paterson I; Sorensen EJ
    Mol Pharmacol; 2006 Nov; 70(5):1555-64. PubMed ID: 16887932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.
    Pryor DE; O'Brate A; Bilcer G; Díaz JF; Wang Y; Wang Y; Kabaki M; Jung MK; Andreu JM; Ghosh AK; Giannakakou P; Hamel E
    Biochemistry; 2002 Jul; 41(29):9109-15. PubMed ID: 12119025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.
    Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF
    Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel.
    Dabydeen DA; Florence GJ; Paterson I; Hamel E
    Cancer Chemother Pharmacol; 2004 May; 53(5):397-403. PubMed ID: 15060743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
    Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
    Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
    Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
    Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization.
    Giannakakou P; Sackett DL; Kang YK; Zhan Z; Buters JT; Fojo T; Poruchynsky MS
    J Biol Chem; 1997 Jul; 272(27):17118-25. PubMed ID: 9202030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
    Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB
    Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural intermediates in the assembly of taxoid-induced microtubules and GDP-tubulin double rings: time-resolved X-ray scattering.
    Diaz JF; Andreu JM; Diakun G; Towns-Andrews E; Bordas J
    Biophys J; 1996 May; 70(5):2408-20. PubMed ID: 9172767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
    Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone.
    Wang M; Xia X; Kim Y; Hwang D; Jansen JM; Botta M; Liotta DC; Snyder JP
    Org Lett; 1999 Jul; 1(1):43-6. PubMed ID: 10822530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
    Kamath K; Jordan MA
    Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.